A019170 Stock Overview
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Shinpoong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩12,760.00 |
52 Week High | ₩22,800.00 |
52 Week Low | ₩9,560.00 |
Beta | 0.93 |
1 Month Change | 8.69% |
3 Month Change | 3.57% |
1 Year Change | -33.99% |
3 Year Change | -87.61% |
5 Year Change | 65.07% |
Change since IPO | 571.43% |
Recent News & Updates
Recent updates
Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?
Mar 07Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?
Feb 01We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide
Jan 05Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?
Dec 10Shareholder Returns
A019170 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -6.1% | -3.0% | -3.0% |
1Y | -34.0% | -0.2% | 0.6% |
Return vs Industry: A019170 underperformed the KR Pharmaceuticals industry which returned -0.2% over the past year.
Return vs Market: A019170 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
A019170 volatility | |
---|---|
A019170 Average Weekly Movement | 10.8% |
Pharmaceuticals Industry Average Movement | 4.6% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A019170's share price has been volatile over the past 3 months.
Volatility Over Time: A019170's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1962 | 828 | n/a | shinpoong.co.kr |
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products.
Shinpoong Pharmaceutical Co.,Ltd Fundamentals Summary
A019170 fundamental statistics | |
---|---|
Market cap | ₩686.73b |
Earnings (TTM) | -₩57.33b |
Revenue (TTM) | ₩200.23b |
3.3x
P/S Ratio-11.4x
P/E RatioIs A019170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A019170 income statement (TTM) | |
---|---|
Revenue | ₩200.23b |
Cost of Revenue | ₩119.95b |
Gross Profit | ₩80.28b |
Other Expenses | ₩137.60b |
Earnings | -₩57.33b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.12k |
Gross Margin | 40.09% |
Net Profit Margin | -28.63% |
Debt/Equity Ratio | 16.6% |
How did A019170 perform over the long term?
See historical performance and comparison